CAM
GSK icon

ClariVest Asset Management’s GSK GSK Stock Holding History

ClariVest Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.04K Hold
27
– – ﹤0.01% 616
2024
Q2 		$1.04K Hold
27
– – ﹤0.01% 616
2024
Q1 		$1.16K Hold
27
– – ﹤0.01% 640
2023
Q4 		$1K Buy
+27
New +$969 ﹤0.01% 655

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClariVest Asset Management's GSK Position: Q3 2024 in Review

ClariVest Asset Management held its GSK (GSK) position steady in Q3 2024 at 27 shares worth $1.04K. The position accounts for ﹤0.01% of the portfolio, ranked #616.

ClariVest Asset Management first reported a position in GSK in Q4 2023 and has held it in 4 quarters since. The position peaked at $1.16K in Q1 2024. 900 funds tracked by Wall St. Rank hold GSK as of Q3 2024.

  • ClariVest Asset Management held 27 shares of GSK worth $1.04K as of Q3 2024.
  • ClariVest Asset Management left its GSK share count unchanged in Q3 2024.
  • GSK made up ﹤0.01% of ClariVest Asset Management's portfolio in Q3 2024, its #616 holding.
  • ClariVest Asset Management first reported a position in GSK in Q4 2023 and has held it in 4 quarters since.
  • ClariVest Asset Management's GSK position peaked at $1.16K in Q1 2024.
  • 900 funds tracked by Wall St. Rank held GSK as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.